- Home
- DAVA vs AMPH Comparison
DAVA vs AMPH Comparison
Compare DAVA & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAVA
- AMPH
- Stock Information
- Founded
- DAVA 2000
- AMPH 1996
- Country
- DAVA United Kingdom
- AMPH United States
- Employees
- DAVA N/A
- AMPH N/A
- Industry
- DAVA EDP Services
- AMPH Biotechnology: Pharmaceutical Preparations
- Sector
- DAVA Technology
- AMPH Health Care
- Exchange
- DAVA Nasdaq
- AMPH Nasdaq
- Market Cap
- DAVA 1.2B
- AMPH 1.2B
- IPO Year
- DAVA 2018
- AMPH 2014
- Fundamental
- Price
- DAVA $18.94
- AMPH $23.82
- Analyst Decision
- DAVA Buy
- AMPH Hold
- Analyst Count
- DAVA 12
- AMPH 3
- Target Price
- DAVA $39.43
- AMPH $43.50
- AVG Volume (30 Days)
- DAVA 475.0K
- AMPH 670.7K
- Earning Date
- DAVA 05-22-2025
- AMPH 05-07-2025
- Dividend Yield
- DAVA N/A
- AMPH N/A
- EPS Growth
- DAVA N/A
- AMPH 17.69
- EPS
- DAVA 0.12
- AMPH 3.06
- Revenue
- DAVA $950,741,765.00
- AMPH $731,967,000.00
- Revenue This Year
- DAVA $9.65
- AMPH $2.15
- Revenue Next Year
- DAVA $8.30
- AMPH $6.64
- P/E Ratio
- DAVA $146.31
- AMPH $7.68
- Revenue Growth
- DAVA N/A
- AMPH 13.59
- 52 Week Low
- DAVA $16.60
- AMPH $22.64
- 52 Week High
- DAVA $34.94
- AMPH $53.96
- Technical
- Relative Strength Index (RSI)
- DAVA 42.70
- AMPH 36.03
- Support Level
- DAVA $16.60
- AMPH $22.84
- Resistance Level
- DAVA $18.89
- AMPH $24.69
- Average True Range (ATR)
- DAVA 1.19
- AMPH 1.17
- MACD
- DAVA 0.27
- AMPH 0.02
- Stochastic Oscillator
- DAVA 50.48
- AMPH 22.26
About DAVA Endava plc (each representing one)
Endava is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2006 in the U.K. and it continues to generate the majority of revenue in the U.K. and Europe. Endava's client base is concentrated in the payments and financial services, technology, media, and telecom industries.
About AMPH Amphastar Pharmaceuticals Inc.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.